Nexalin names Abbott, Medtronic veteran Robert DiTota senior strategic advisor for global commercialization

By Public Technologies
  • Nexalin Technology appointed neuromodulation executive Robert DiTota as senior strategic advisor for global commercialization, effective Sept. 15, 2026.
  • DiTota will advise management on commercial strategy, international distribution, market development, go-to-market planning, commercial infrastructure, organizational buildout.
  • He spent more than 20 years in neuromodulation at Abbott, most recently divisional VP of sales for North America commercial neuromodulation.
  • DiTota previously worked at Medtronic for nine years, supporting deep brain stimulation in New York and the Activa platform launch.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nexalin Technology Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609290900PRIMZONEFULLFEED9835954) on September 29, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk